Nuzenio

Neurosense

Neurosense news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 10 latest news signals 6 publisher sources 100/100 entity strength

Latest news

Health Canada review path for PrimeC: NeuroSense (NASDAQ: NRSN) - Stock TitanStock Titan · Thu, 06 Aug 2026 15:56:23 GMTNeuroSense Completes PrimeC Pre-NDS Process and Advances Toward December 2026 Filing with Health Canada - PR NewswirePR Newswire · Thu, 06 Aug 2026 15:29:00 GMTNeuroSense Therapeutics Ltd. SEC Filing (Aug 3, 2026) - Stock TitanStock Titan · Mon, 03 Aug 2026 10:13:46 GMTNeuroSense Therapeutics (NRSN) revises Capital on Demand share sales deal - Stock TitanStock Titan · Fri, 31 Jul 2026 20:16:21 GMTNeuroSense Therapeutics (NRSN) Plunges 14% – Testing Critical Support at $0.46 - Hull Moving Average - dars.gov.etdars.gov.et · Wed, 29 Jul 2026 07:00:00 GMTNeuroSense Therapeutics (NRSN) Plunges 14% – Testing Critical Support at $0.46 - Fibonacci Entry Signals - dars.gov.etdars.gov.et · Wed, 29 Jul 2026 07:00:00 GMTPrice to earnings forward of NeuroSense Therapeutics Ltd. – BOATS:NRSNW - TradingViewTradingView · Wed, 29 Jul 2026 00:23:57 GMTDeveloper to seek approval in Canada for ALS treatment aiding survival - ALS News TodayALS News Today · Tue, 28 Jul 2026 16:42:07 GMT

Timeline

Thu, 06 Aug 2026 15:56:23 GMTHealth Canada review path for PrimeC: NeuroSense (NASDAQ: NRSN) - Stock Titan
Thu, 06 Aug 2026 15:29:00 GMTNeuroSense Completes PrimeC Pre-NDS Process and Advances Toward December 2026 Filing with Health Canada - PR Newswire
Mon, 03 Aug 2026 10:13:46 GMTNeuroSense Therapeutics Ltd. SEC Filing (Aug 3, 2026) - Stock Titan
Fri, 31 Jul 2026 20:16:21 GMTNeuroSense Therapeutics (NRSN) revises Capital on Demand share sales deal - Stock Titan
Wed, 29 Jul 2026 07:00:00 GMTNeuroSense Therapeutics (NRSN) Plunges 14% – Testing Critical Support at $0.46 - Hull Moving Average - dars.gov.et
Wed, 29 Jul 2026 07:00:00 GMTNeuroSense Therapeutics (NRSN) Plunges 14% – Testing Critical Support at $0.46 - Fibonacci Entry Signals - dars.gov.et

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Neurosense.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

6 distinct publisher/source names are currently connected to this entity page.